86 related articles for article (PubMed ID: 3924422)
1. Comparative in vitro evaluation of the antimicrobial activity of flurithromycin by means of the MS-2 Abbott Research System.
Periti P; Nicoletti P; Novelli A
Chemioterapia; 1985 Apr; 4(2):156-60. PubMed ID: 3924422
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
Nord CE; Lindmark A; Persson I
J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
[No Abstract] [Full Text] [Related]
3. In vitro activity of flurithromycin, a novel macrolide antibiotic.
Gialdroni Grassi G; Alesina R; Bersani C; Ferrara A; Fietta A; Peona V
Chemioterapia; 1986 Jun; 5(3):177-84. PubMed ID: 3487389
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activity, serum binding and binding activity interactions of the macrolides A-56268, RU-28965, erythromycin and josamycin.
Dette GA; Knothe H; Koulen G
Drugs Exp Clin Res; 1987; 13(9):567-76. PubMed ID: 2962847
[TBL] [Abstract][Full Text] [Related]
5. The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates.
Dibb WL; Ragnhildstveit E
NIPH Ann; 1986 Dec; 9(2):61-3. PubMed ID: 3101004
[TBL] [Abstract][Full Text] [Related]
6. Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials.
Lohray BB; Lohray VB; Srivastava BK; Gupta S; Solanki M; Pandya P; Kapadnis P
Bioorg Med Chem Lett; 2006 Mar; 16(6):1557-61. PubMed ID: 16386420
[TBL] [Abstract][Full Text] [Related]
7. Daptomycin in vitro susceptibility in European Gram-positive clinical isolates.
Fluit AC; Schmitz FJ; Verhoef J; Milatovic D
Int J Antimicrob Agents; 2004 Jul; 24(1):59-66. PubMed ID: 15225863
[TBL] [Abstract][Full Text] [Related]
8. In-vitro antimycoplasmal activity of flurithromycin.
Furneri PM; Bisignano G; Cerniglia G; Tempera G; Nicoletti G
J Antimicrob Chemother; 1995 Jan; 35(1):161-5. PubMed ID: 7768764
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibitory activity of spiramycin against Haemophilus influenzae.
Dabernat H; Delmas C
Chemioterapia; 1987 Jun; 6(2 Suppl):158-9. PubMed ID: 3509933
[No Abstract] [Full Text] [Related]
10. The post-antibiotic effects of linezolid against Gram-positive pathogens.
Hosgor-Limoncu M; Ermertcan S; Tasli H; Aydemir S
Saudi Med J; 2007 Apr; 28(4):551-4. PubMed ID: 17457476
[TBL] [Abstract][Full Text] [Related]
11. Frequencies of resistance to Melaleuca alternifolia (tea tree) oil and rifampicin in Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis.
Hammer KA; Carson CF; Riley TV
Int J Antimicrob Agents; 2008 Aug; 32(2):170-3. PubMed ID: 18571379
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity studies of echinomycin antibiotics against drug-resistant and biofilm-forming Staphylococcus aureus and Enterococcus faecalis.
Socha AM; Laplante KL; Russell DJ; Rowley DC
Bioorg Med Chem Lett; 2009 Mar; 19(5):1504-7. PubMed ID: 19185486
[TBL] [Abstract][Full Text] [Related]
13. Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.
Kuenzi B; Segessenmann C; Gerber AU
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():39-46. PubMed ID: 3501426
[TBL] [Abstract][Full Text] [Related]
14. [Synthesis of derivatives of (9S) -9-hydroxyl-12-methylene erythromycin A and their antibacterial activity in vitro].
Xu P; Yang Y; Shi Y; Lei PS; Liu L
Yao Xue Xue Bao; 2007 May; 42(5):497-501. PubMed ID: 17703771
[TBL] [Abstract][Full Text] [Related]
15. [In vitro activity of josamycin in a comparison of Staphylococcus aureus, Streptococcus pyogenes and Streptococcus pneumoniae].
Andreoni O
Minerva Med; 1983 Mar; 74(12):619-24. PubMed ID: 6339995
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility studies with josamycin and erythromycin.
Strausbaugh LJ; Dilworth JA; Gwaltney JM; Sande MA
Antimicrob Agents Chemother; 1976 Mar; 9(3):546-8. PubMed ID: 4012
[TBL] [Abstract][Full Text] [Related]
17. Cationic peptide of the male reproductive tract, HE2alpha, displays antimicrobial activity against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis.
Liao M; Ruddock PS; Rizvi AS; Hall SH; French FS; Dillon JR
J Antimicrob Chemother; 2005 Nov; 56(5):957-61. PubMed ID: 16195256
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the in vitro post-antibiotic effect of C14 macrolides (erythromycin and roxithromycin) and C16 macrolides (josamycin and spiramycin) against Staphylococcus aureus].
Rolin O; Bouanchaud DH
Pathol Biol (Paris); 1989 May; 37(5):375-7. PubMed ID: 2780094
[TBL] [Abstract][Full Text] [Related]
19. The antibacterial activity of tramadol against bacteria associated with infectious complications after local or regional anesthesia.
Tamanai-Shacoori Z; Shacoori V; Jolivet-Gougeon A; Vo Van JM; Repère M; Donnio PY; Bonnaure-Mallet M
Anesth Analg; 2007 Aug; 105(2):524-7. PubMed ID: 17646517
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of roxithromycin against respiratory and skin pathogens.
Pechére JC; Auckenthaler R
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():1-5. PubMed ID: 3501424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
